Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians
- 11 April 2020
- journal article
- letter
- Published by Elsevier BV in Blood Cells, Molecules, and Diseases
- Vol. 83, 102439
- https://doi.org/10.1016/j.bcmd.2020.102439
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- COVID-19 in posttransplant patients—report of 2 casesAmerican Journal of Transplantation, 2020
- Latest updates on COVID-2019: A changing paradigm shiftJournal of Medical Virology, 2020
- Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptomsGut, 2020
- Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington StateTransfusion, 2020
- Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive studySignal Transduction and Targeted Therapy, 2020
- How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID‐19 threat?British Journal of Haematology, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Anxiety and depression in patients with acute leukaemia treated with hematopoietic stem cell transplantation.2019